Affordable Access

Publisher Website

RAGE: A New Target for the Prevention and Treatment of the Vascular and Inflammatory Complications of Diabetes

Authors
Journal
Trends in Endocrinology and Metabolism
1043-2760
Publisher
Elsevier
Publication Date
Volume
11
Issue
9
Identifiers
DOI: 10.1016/s1043-2760(00)00311-8
Disciplines
  • Medicine

Abstract

Abstract Although the underlying causes of hyperglycemia are multiple, a common thread associated with high levels of blood sugar is the development of a range of vascular and inflammatory complications that might seriously limit the quality and duration of life in affected individuals. Despite multiple aggressive efforts to prevent complications, diabetes remains the leading disease consuming healthcare dollars in the USA. This review focuses on the role of advanced glycation endproducts (AGEs) and their interaction with their signal-transduction AGE receptor (RAGE), in vascular and inflammatory cell perturbation and the chronic activation that underlies diabetes. Our studies provide mechanistic insights into complications within the macrovasculature and those ensuing from an exaggerated host response to invading bacteria, and suggest that blockade of RAGE might provide a potent and safe strategy for the prevention of complications that typify long-term diabetes.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

RAGE: a new target for the prevention and treatmen...

on Trends in endocrinology and me... November 2000

Targeting aldose reductase for the treatment of di...

on Journal of Medicinal Chemistry Mar 12, 2015

New targets for the treatment of vascular diseases...

on IDrugs : the investigational d... November 1998

[Vascular complications of diabetes mellitus, prev...

on Vnitr̆ní lékar̆ství February 1983
More articles like this..